Chemical Formula: C35H56O6

Chemical Formula C35H56O6

Found 69 metabolite its formula value is C35H56O6

(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside

2-({14-[(3E)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4076676)


(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is found in fruits. (3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is a constituent of Cucurbita pepo and Momordica charantia (bitter melon). Constituent of Cucurbita pepo and Momordica charantia (bitter melon). (3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside is found in fruits.

   

22-Angeloylbarringtogenol C

3,5,10-Trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicen-4-yl (2Z)-2-methylbut-2-enoic acid

C35H56O6 (572.4076676)


22-Angeloylbarringtogenol C is found in tea. 22-Angeloylbarringtogenol C is a constituent of Camellia sinensis var. assamica (Assam tea). Constituent of Camellia sinensis variety assamica (Assam tea). 22-Angeloylbarringtogenol C is found in tea.

   

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoic acid

C35H56O6 (572.4076676)


DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C35H56O6 (572.4076676)


DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0)

(2S)-2-(Decanoyloxy)-3-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C35H56O6 (572.4076676)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

(2R)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C35H56O6 (572.4076676)


DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0)

(2S)-3-(Decanoyloxy)-2-hydroxypropyl (4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoic acid

C35H56O6 (572.4076676)


DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

3-epi-Skimmiarepin A

3-epi-Skimmiarepin A

C35H56O6 (572.4076676)


   

4beta,9alpha,20-trihydroxy-13alpha-pentadecanoate-1,6-tigliadien-3-one

4beta,9alpha,20-trihydroxy-13alpha-pentadecanoate-1,6-tigliadien-3-one

C35H56O6 (572.4076676)


   

Schiwalligenin A4

Schiwalligenin A4

C35H56O6 (572.4076676)


   
   

22-O-(3,3-dimethylacryloyl)-A1-barrigenol|22-O-(3-Methyl-2-butenoyl) -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol

22-O-(3,3-dimethylacryloyl)-A1-barrigenol|22-O-(3-Methyl-2-butenoyl) -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol

C35H56O6 (572.4076676)


   

7-desmethyldeoxyneofusapyrone

7-desmethyldeoxyneofusapyrone

C35H56O6 (572.4076676)


   

Barringtogenol B|Barringtogenol B; 3beta,21beta,22alpha,28-Tetrahydroxy-16alpha-angeloyloxy-oleanen-(12)|Barrintogenol B

Barringtogenol B|Barringtogenol B; 3beta,21beta,22alpha,28-Tetrahydroxy-16alpha-angeloyloxy-oleanen-(12)|Barrintogenol B

C35H56O6 (572.4076676)


   

22-Dehydroclerosterol glucoside

22-Dehydroclerosterol glucoside

C35H56O6 (572.4076676)


   

22-Angeloyl -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol|Olean-12-en-3beta,15alpha,16alpha,22alpha,28-pentol-22-angelat

22-Angeloyl -(3beta,15alpha,16alpha,22alpha)-12-Oleanene-3,15,16,22,28-pentol|Olean-12-en-3beta,15alpha,16alpha,22alpha,28-pentol-22-angelat

C35H56O6 (572.4076676)


   
   

24beta-ethylcholesta-5,9(11),22E-trien 3-O--beta-D-glucoside|elaeagnoside

24beta-ethylcholesta-5,9(11),22E-trien 3-O--beta-D-glucoside|elaeagnoside

C35H56O6 (572.4076676)


   

stigmast-7-en-3beta-ol 3-O-beta-D-glucopyranoside

stigmast-7-en-3beta-ol 3-O-beta-D-glucopyranoside

C35H56O6 (572.4076676)


   

7alpha-n-pentadecanoyloxy-6beta,12-dihydroxy-abieta-8,12-diene-11,14-dione

7alpha-n-pentadecanoyloxy-6beta,12-dihydroxy-abieta-8,12-diene-11,14-dione

C35H56O6 (572.4076676)


   

22-Angeloylbarringtogenol C

3,5,10-trihydroxy-4a-(hydroxymethyl)-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicen-4-yl (2Z)-2-methylbut-2-enoate

C35H56O6 (572.4076676)


   

(3b,5a,22E,24S)-Stigmasta-7,22,25-trien-3-ol 3-glucoside

2-({14-[(3E)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4076676)


   

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

DG(10:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0)

C35H56O6 (572.4076676)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/10:0/0:0)

C35H56O6 (572.4076676)


   

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

DG(10:0/0:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C35H56O6 (572.4076676)


   

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0)

DG(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/0:0/10:0)

C35H56O6 (572.4076676)


   

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

DG(10:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0)

C35H56O6 (572.4076676)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/10:0/0:0)

C35H56O6 (572.4076676)


   

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

DG(10:0/0:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C35H56O6 (572.4076676)


   

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0)

DG(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/0:0/10:0)

C35H56O6 (572.4076676)


   

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

DG(10:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0)

C35H56O6 (572.4076676)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/10:0/0:0)

C35H56O6 (572.4076676)


   

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

DG(10:0/0:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C35H56O6 (572.4076676)


   

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0)

DG(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/0:0/10:0)

C35H56O6 (572.4076676)


   

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

DG(10:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0)

C35H56O6 (572.4076676)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/10:0/0:0)

C35H56O6 (572.4076676)


   

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

DG(10:0/0:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C35H56O6 (572.4076676)


   

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0)

DG(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/0:0/10:0)

C35H56O6 (572.4076676)


   

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

DG(10:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0)

C35H56O6 (572.4076676)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/10:0/0:0)

C35H56O6 (572.4076676)


   

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

DG(10:0/0:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C35H56O6 (572.4076676)


   

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0)

DG(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/0:0/10:0)

C35H56O6 (572.4076676)


   

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-15-[(3S,5R)-5-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethyl-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] 3-methylbutanoate

[(1S,2R,3R,5R,7R,10S,11R,14R,15S)-15-[(3S,5R)-5-[(2S)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethyl-7-pentacyclo[12.3.1.01,14.02,11.05,10]octadecanyl] 3-methylbutanoate

C35H56O6 (572.4076676)


   

skimmiarepin A

skimmiarepin A

C35H56O6 (572.4076676)


A natural product found in Aegle marmelos.

   
   
   
   
   

1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl pentadecanoate

1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0²,⁶.0¹¹,¹³]pentadeca-3,8-dien-13-yl pentadecanoate

C35H56O6 (572.4076676)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhepta-3,6-dien-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H56O6 (572.4076676)


   

2-[(1s,2s,3s,5s)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]-3-hydroxy-5-[(2s,3s,4e,6e,8r,9z,12s)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]cyclohexa-2,4-dien-1-one

2-[(1s,2s,3s,5s)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]-3-hydroxy-5-[(2s,3s,4e,6e,8r,9z,12s)-3-hydroxy-6,8,10,12-tetramethyloctadeca-4,6,9-trien-2-yl]cyclohexa-2,4-dien-1-one

C35H56O6 (572.4076676)


   

(1s,2r,3r,5s,7s,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

(1s,2r,3r,5s,7s,10s,11r,14r,15s)-15-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-3-hydroxy-2,6,6,10-tetramethylpentacyclo[12.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]octadecan-7-yl 3-methylbutanoate

C35H56O6 (572.4076676)


   

(4as,9s,10s,10as)-6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl pentadecanoate

(4as,9s,10s,10as)-6,10-dihydroxy-7-isopropyl-1,1,4a-trimethyl-5,8-dioxo-2,3,4,9,10,10a-hexahydrophenanthren-9-yl pentadecanoate

C35H56O6 (572.4076676)